.avif)
SAN DIEGO & PARIS - Scientist.com, the life science industry’s leading online marketplace for outsourced research, and the Brain and Spine Institute incubator, iPEPS-ICM, the first innovation accelerator dedicated to brain diseases in France, announced that Cerebrum Therapeutics won a biotech pitch competition with a prize package that includes 6 months free rent at iPEPS’ state-of-the-art facilities located in Paris’ 13th district and $10K USD in research services provided through the Scientist.com marketplace. Runner-up Cairn Biosciences will receive 3 months free rent at iPEPS and $6K USD in research services through Scientist.com.
“It is an honor to be recognized by the Brain and Spine Institute and Scientist.com for our efforts to develop novel treatments for brain diseases and injuries,” said Vincent Serra, CEO and Co-Founder of Cerebrum Therapeutics. “The prizes will go a long way toward accelerating our breakthrough approach to testing promising chemical and biological properties in the CNS field.”
Based in Paris, France, Cerebrum Therapeutics develops first-in-class small chemical molecules for the treatment of neurodegenerative diseases and brain injuries. Their first program is dedicated to development of a new drug to target the Tauopathy indication, with orphan drug designation. San Francisco, USA-based Cairn Biosciences, who finished second in the competition, develops next-generation therapeutics that overcome resistance to cancer therapy. Cairn’s drug discovery engine addresses the profound unmet need for new tools to decipher cellular complexity and enable scalable discovery of groundbreaking therapies.
“This startup call is aimed at helping young biotech entrepreneurs fast track the development of their innovative projects in one of the most thriving research and innovation ecosystems in Europe,” commented Dan Kagan, PhD, COO of Scientist.com. “It’s these types of collaborative efforts that will help find cures for neurological disorders, which affect nearly a billion people globally.”
About the Brain and Spine Institute
Located in the heart of the Pitié-Salpêtrière University Hospital Center, the first neurology hospital in France, the Brain and Spine Institute (ICM) is a strong link between basic research and the clinical world. The Institute consists of over 700 researchers and clinicians, 12 cutting-edge technological platforms and 1000m² office space intended for incubation of startups. The objective is to produce ambitious research by combining scientific creativity and therapeutic purpose.
.webp)
Scientist.com
Scientist.comは、科学研究のアウトソーシングという複雑な業務のために構築された、世界最大かつ初のプラットフォームです。
私たちは、製薬・バイオテクノロジー企業が、創薬や前臨床研究から臨床開発、製造、メディカルアフェアーズ、そして商業化に至るまで、パイプラインのあらゆる段階を支えるプロバイダーとの関係を構築、管理、拡大できるよう支援しています。一元化されたプラットフォームを通じて、組織は6,000社以上のグローバルなプロバイダーネットワークにアクセスし、調達ワークフローの効率化、コンプライアンスの維持、サプライヤー関係の管理を実現するとともに、データに基づいた洞察を活用して、より迅速かつ的確な意思決定を行うことが可能です。
現在、Scientist.comは世界の製薬企業トップ30社のうち24社を含む130以上のライフサイエンス関連組織を支援しており、業務の複雑さを軽減し、開発期間を短縮し、イノベーションをより迅速に患者へ届けるためのサポートを行っています。私たちの使命は、2050年までに人類のあらゆる疾患を治癒可能にすることです。